Basic Information
| LncRNA/CircRNA Name | RP5-1024C24.1 |
| Synonyms | NA |
| Region | GRCh38_11:30584130-30630508 |
| Ensemble | ENSG00000254489 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | papillary thyroid cancer |
| ICD-0-3 | NA |
| Methods | RNA-seq, qPCR |
| Sample | papillary thyroid cancer tissues |
| Expression Pattern | down-regulated |
| Function Description | LncRNA RP5-1024C24.1,AC007255.8, and HOXD-AS1 expression was significantly related to clinical stage, Late clinical stage samples had reduced expression of lncRNA RP5-1024C24.1 |
| Pubmed ID | 28817151 |
| Year | 2017 |
| Title | Comprehensive analysis of long noncoding RNA-mRNA co-expression patterns in thyroid cancer. |
External Links
| Links for RP5-1024C24.1 | GenBank HGNC NONCODE |
| Links for papillary thyroid cancer | OMIM COSMIC |